Gadolinium Update.

Slides:



Advertisements
Similar presentations
Update on MR Enterography PMA GI Conference January 4, 2011 Alvin Yamamoto, MD Commonwealth Radiology Associates.
Advertisements

Contrast-Enhanced Neuro MRA in the NSF Era: Possible Contrast Dose Reduction with a High- Relaxivity Contrast Agent Matthew J. Kuhn, MD Department of.
Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
The hype about hyper signals
Bladder Cancer: A New Era in Treatment
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Chronic HCV Infection and CKD
CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: Implementing Paradigms in Clinical Practice.
Clinical Trials in IBD.
A Review of the Critical Role of Imaging in Primary Liver Malignancy
New Guidelines to Prevent SCD: What You Need to Know
MR Imaging in Children.
5 Things NPs and PAs Need to Know About Tardive Dyskinesia
CDK 4 and 6 Inhibitors in HR-Positive Breast Cancer: A Clinical Update
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Progression After Cancer Immunotherapy in Advanced NSCLC
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
سرطان الثدي Breast Cancer
Pediatric Antiepileptic Treatment Strategies
COPD Management.
Updates on Outcomes for Novel T2D Therapies
Updates in Management of Atopic Dermatitis From Real Patient Cases
Direct-To-Consumer Genetic Testing
Statins and the Elderly Patient
Abbreviated Protocols for Breast Cancer Screening
Navigating the Data and Evolving Our Approach
IL-17 Inhibitors in the Management of Psoriatic Disease
Asthma and Atopic Comorbidities
Assessing Disease Progression in MS Treatment
Managing gBRCA-Positive Metastatic Breast Cancer
Are We Closer to Personalized Medicine in MS?
Advanced Lung Cancers: What's on the Horizon?
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Hyperhidrosis Is Burdensome!
Gene Therapy: Past, Present, and Future
Tackling Atopic Dermatitis
Immunotherapy for cSCC
HIV Treatment: What Can You Do to Get and Keep Patients in Care?
The Primary Care Guide to New CGM Devices and the AGP
Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.
Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.
Updates in the Management of Acute Promyelocytic Leukemia
The Road to Quality Improvement in HER2-Positive Breast Cancer
Scientific Update.
Guide to Atopic Dermatitis
Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.
Understanding the Updated Guidelines for ALK Testing in NSCLC
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
Optimizing Joint Health in Hemophilia
Healthy With HIV.
Latest Lipid Guidelines in Perspective
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Improving Overall Health
Peanut Allergy Immunotherapy
Clinical Challenges and Updates in Managing Seizure Clusters
Prioritizing Prevention of HPV-Related Disease
Managing Pain in the 21st Century
Renal Function and Myeloma Therapeutics
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
HAE Prophylaxis.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Using Biomarkers in MS: Initiating With the Right Therapy in Clinical Practice.
Lipids, the Heart, and the Kidney
Immune Checkpoint Inhibitors in Lung Cancer
Expert Perspectives.
Foundations of Asthma.
First Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies Bird S et al. Published Online: August.
Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI Neither the.
Presentation transcript:

Gadolinium Update

Gadolinium-Based Contrast Agents Background

Gadolinium-Based Contrast Agents Background (cont)

Basic Structures of Commercially Available GBCAs

GBCAs and NSF

2018 ACR Manual, Version 10.3

Risk Factors for CKD

Gadolinium Use in Renal Impairment ACR and FDA Guidelines

NSF Key Takeaways

GBCA Deposition and Retention in the Brain Background

GBCAs Retention or Deposition?

Are There Clinical Correlates?

GBCA Deposition and Retention FDA Response

Intracranial GBCA Deposition and Retention EMA Response

Summary What is Known About Gd Deposition and Retention?

GBCA Use During Pregnancy

GBCA-Enhanced MRI for Breast Cancer Screening

GBCA Use in Pediatric Populations

Concluding Remarks

Abbreviations